Pharma Asia. News, analysis and practical guides on Pakistan’s pharmaceutical industry, from the team behind Pharma Asia, Pakistan’s biggest pharma sector exhibition.
The 24th Pharma Asia opens on 20 October with more than 230 exhibitors across seven halls and the International Pharma Convention alongside. Here is what is on.
From a trade show to the platform where manufacturers, suppliers, regulators and buyers meet every year — what Pharma Asia does for the industry.
Prices of non-essential medicines were freed in February 2024. Officials now report over 99% availability, while the pricing framework faces a fresh…
Pakistan is at WHO Maturity Level 2 and exports medicines to 52 countries. The health minister expects Level 3 by April 2027.
The July 2026 B2B conference ended with contracts and MoUs focused on local production of vaccines, pharmaceutical raw materials and medical devices.
Regulators now have a global guideline, and continuous lines have shortened release times and approvals. Where the technology stands.
India’s bulk-drug incentive scheme has attracted Rs5,210 crore and is commissioning plants for penicillin G, clavulanic acid and paracetamol’s raw…
The organiser’s post-show report for the 23rd edition: who came, what exhibitors achieved and how visitors rated the show.
Retail medicine sales rose 14.88% to Rs1.251 trillion in the year to June 2026, while units grew less than 1%. National companies hold nearly 80% of…
Former DRAP chiefs, PPMA chairmen, multinational heads and global machinery makers have all spoken at the convention held alongside Pharma Asia.
Listed drug makers earned Rs42.2 billion in FY26 on sales of Rs377.9 billion, with gross margins at an all-time high of 42.8%.
Pakistan Pharma Vision 2030, exports, PIC/S compliance, AI and track and trace dominated the 2025 convention at Pharma Asia.
